Cargando…
POL7085 or anti‐CCL28 treatment inhibits development of post‐paramyxoviral airway disease
INTRODUCTION: Asthma is major health burden throughout the world, and there are no therapies that have been shown to be able to prevent the development of disease. A severe respiratory paramyxoviral infection early in life has been demonstrated to greatly increase the risk of developing asthma. We h...
Autores principales: | Buelow, Becky J., Rohlfing, Michelle, Jung, Françoise, Douglas, Garry J., Grayson, Mitchell H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418136/ https://www.ncbi.nlm.nih.gov/pubmed/28474501 http://dx.doi.org/10.1002/iid3.147 |
Ejemplares similares
-
Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation
por: Daubeuf, François, et al.
Publicado: (2015) -
Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene
por: Douglas, Jordan, et al.
Publicado: (2021) -
Shared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategies
por: Bowden, Thomas A., et al.
Publicado: (2010) -
Reduced inflammation and altered innate response in neonates during paramyxoviral infection
por: Bhattacharya, Somashubhra, et al.
Publicado: (2011) -
Effect of Grain Structure and Quenching Rate on the Susceptibility to Exfoliation Corrosion in 7085 Alloy
por: Cao, Puli, et al.
Publicado: (2023)